Ping Zhu
,

Credentials

MD, MMed, PhD

Assistant Professor

Biography

Bio

Dr. Zhu earned her PhD in epidemiology, biostatistics, and cancer from the University of Texas Health Science Center at Houston, and her MD and Master of Medicine in epidemiology and health statistics from Fudan University in Shanghai, China. Prior to coming to the U, she was a biostatistician at the University of Texas Health Science Center.

Dr. Zhu has a comprehensive background and specific expertise in epidemiology and biostatistics with more than 10 years of research experience, including study design (cross-sectional, cohort, and clinical trial), data management/data cleanup, statistical analysis, and manuscript writing. She has developed more than 11 population-based studies using 6 national-scale datasets as a co-PI and statistician and has collaborated with a multidisciplinary team that included neuro-oncology, neurosurgery, radiology, and pathology in more than 10 clinical research projects.

Research Summary

Dr. Zhu's research interest is to explore the contributors and related impacts on the outcomes of primary brain/central nervous system tumors and brain cancer metastases.

Education

PhD, The University of Texas Health Science Center at Houston, Texas, U.S. School of Public Health

Major: Epidemiology, Biostatistics, Cancer

M.Med. (Master of Medicine), Fudan University, Shanghai, China School of Public Health

Major: Epidemiology and Health Statistics

MD, Fudan University, Shanghai, China School of Public Health

Major: Preventive Medicine

Licensures and Certifications

Fulfilled the Ph.D. Epidemiology Preliminary Examination,

Obtained the doctor license as Public Health Physician, National Medical Licensing Examination (NMLE)

Certified Design and Management of Clinical Trials Practicum, (MD. Anderson Cancer Center)

Honors and Recognition

‘Excellent’ in Double-Bind Evaluation of Master Graduation Thesis

2012

Third Prize Scholarship for Outstanding Students, Fudan University

2011

First Prize Scholarship for Outstanding Students, Fudan University

2010

Annual Scholarship for Outstanding Students each year for 5 years, Fudan University

2009

Outstanding Student Leadership

2007

Professional Memberships

Journal of Neurosurgery, Reviewer

Cancer, Reviewer

Neuro-Oncology, Reviewer

World Neurosurgery, Reviewer

AMIA 2021 Informatics Summit, Reviewer

Reviewer for the AMIA 2020 Annual Symposium

Society for Neuro-Oncology (SNO)

Selected Publications

Studies on the determinants and changes related to the natural CD4＋ T cell counts among antiretroviral treatment-naive HIV/AIDS patients in Dehong prefecture.

A Survey on Patient’s Complaint and Solutions to Conflict of Doctor-Patient in Shanghai. Chinese Journal of Hospital Administration

Estimation and projection on HIV/AIDS through application of Estimation and Projection Package and Spectrum models, in Taizhou prefecture.

Studies on the changes related to the natural CD4＋T cell counts among antiretroviral treatment-naive HIV/AIDS patients in Taizhou prefecture.

Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Focally Recurrent Glioblastoma.

Impact of facility type and volume in low-grade glioma outcomes.

CXCR4 is a Potential Therapeutic Target for Glioblastoma and Diffuse Intrinsic Pontine Gliomas.

Selected Presentations

Zhu, P. "Predictors Associated with Long-term Survivorship for Patients with Glioblastoma using the National Cancer Database (NCDB)", The 25th annual meeting of the SNO, Austin, Texas, November 01, 2020.

Zhu, P. "The detrimental effect of biopsy preceding resection in surgically accessible Glioblastomas: Results from the National Cancer Database", The 25th annual meeting of the Society for Neuro-Oncology (SNO), Austin, Texas, United States. November 01, 2020.

Zhu, P. "Reoperation in molecular subtypes of recurrent glioblastoma", The 25th annual meeting of the SNO, Austin, Texas, November 01, 2020.

Zhu, P. "Diffuse gliomas with FGFR alterations, histopathological features, genetic alterations, and potential clinical implications", The 96th Annual Meeting of American Association of Neuropathologist, Virtual Meeting, June 01, 2020.

Zhu, P. "Impact of Race and Geographic Location on IDH Mutations and Glioblastoma Survival. Neuro-Oncology", The 24th annual meeting of the SNO, Pheonix, Arizona, November 01, 2019.

Zhu, P. "PATH-24. CXCR4 is a Potential Therapeutic Target for Glioblastoma and Diffuse Intrinsic Pontine Gliomas", The 24th annual meeting of the SNO, Pheonix, Arizona, November 01, 2019.

Zhu, P. "Comparative analysis of Overall Survival and Adverse Events by Adjuvant Treatment Modalities in Elderly Patients with Glioblastoma Using the SEER-Medicare Database", The 24th annual meeting of the SNO, Pheonix, Arizona, November 01, 2019.

Zhu, P. "Impact of access to clinical trials, multidisciplinary environment, and health care providers on outcomes of patients with newly diagnosed glioblastoma using SEER-Medicare dataset", The American Society of Clinical Oncology (ASCO) annual meeting, Chicago, Illinois, United States. May 01, 2019.

Zhu, P. " Impact of Travel Distance to Care Facility on Survival in Patients with Glioblastoma: A Retrospective Study Using the National Cancer Database", The 71st American Academy of Neurology annual meeting, Philadelphia, Pennsylvania, May 01, 2019.

Zhu, P. "Associations of timing of adjuvant therapies, radiation fractions and radiation doses with glioblastoma survival: A retrospective cohort analysis using the National Cancer Database and SEER-Medicare database", The 23rd annual meeting of the SNO, New Orleans, Louisiana, November 01, 2018.

Zhu, P. "Improved Survival in Patients with Low-Grade Glioma Undergoing Treatment at Academic and High-Volume Facilities", CNS Tumors: 2018 Tumor Section Satellite Symposium, Houston, Texas, October 01, 2018.

Zhu, P. "Gamma Knife Stereotactic Radiosurgery and Bevacizumab can be safely used to prolong survival for focally recurrent Glioblastoma", Congress of Neurological Surgeons (CNS) Annual meeting, Houston, Texas, October 01, 2018.

Zhu, P. "Timing of adjuvant treatments on glioblastoma survival: A retrospective cohort analysis based on the National Cancer Database", The 18th Biennial Canadian Neuro-Oncology Meeting, Banff, Canada. May 01, 2018.

Zhu, P. "PATH-31. Elevation of YKL-40, normalized to ceruloplasmin, in cerebrospinal fluid is associated with glioblastoma recurrence", The 22nd annual meeting of the SNO, San Francisco, California, November 01, 2017.

Zhu, P. "urvival benefit of glioblastoma patients after FDA approval of bevacizumab, a population-based study using SEER, TCR, and NCDB databases, Neuro-Oncology", The 22nd annual meeting of the SNO, San Francisco, California, November 01, 2017.

Zhu, P. "HOUT-12. Improved survival of glioblastoma patients treated at academic cancer programs: A hospital-based study from the National Cancer Database", The 22nd annual meeting of the SNO, San Francisco, California, November 01, 2017.

Zhu, P. "Postmortem evaluation of end-organ toxicity in patients with glioblastoma treated with temozolomide, bevacizumab and irinotecan", The 5th World Federation of Neuro-Oncology Societies (WFNOS) Meeting, Zurich, Switzerland. May 01, 2017.